Medication info
Covalasabel Tablets 160/12.5 mg

Covalasabel Tablets 160/12.5 mg

Prescription medicationTabletOral
Ingredient · strength
Valsartan›160mg / 1 tabletHydrochlorothiazide›12.5mg / 1 tablet
Manufacturer / importer
Jongkundige Co., Ltd.
Appearance
Dark red oval film-coated tablets
Packaging
98 tablets (14 tablets/PTP x 7)
Approval status
Active

MFDS item code 200808273 · Notified 2008.07.31 · Insurance code 643304900

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults
Adult dose
○ Adults The recommended dose is 1 tablet of valsartan 80 mg/hydrochlorothiazide 12.5 mg once daily. It may be taken with or without food, with a small amount of water. Valsartan 160 mg/hydrochlorothiazide 12.5 mg is for patients prescribed valsartan 160 mg/hydrochlorothiazide 12.5 mg to lower blood pressure. The blood pressure-lowering effect reaches its maximum after 2 ~ 4 weeks. ○ Patients with renal impairment No dose adjustment is necessary in patients with mild to moderate renal impairment (creatinine clearance of 30 mL/min or higher). ○ Patients with hepatic impairment In patients with mild to moderate hepatic impairment without cholestasis, do not use more than 80 mg of valsartan per day.

Ingredients

Manufacturer
Jongkundige Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

This medication is used to effectively lower blood pressure in patients with essential hypertension whose blood pressure is not adequately controlled with monotherapy.

How to take

Adult dose

○ Adults The recommended dose is 1 tablet of valsartan 80 mg/hydrochlorothiazide 12.5 mg once daily. It may be taken with or without food, with a small amount of water. Valsartan 160 mg/hydrochlorothiazide 12.5 mg is for patients prescribed valsartan 160 mg/hydrochlorothiazide 12.5 mg to lower blood pressure. The blood pressure-lowering effect reaches its maximum after 2 ~ 4 weeks. ○ Patients with renal impairment No dose adjustment is necessary in patients with mild to moderate renal impairment (creatinine clearance of 30 mL/min or higher). ○ Patients with hepatic impairment In patients with mild to moderate hepatic impairment without cholestasis, do not use more than 80 mg of valsartan per day.

Precautions

This medication can cause serious damage to the fetus if taken during pregnancy, especially during the second and third trimesters, so it should be discontinued immediately once pregnancy is confirmed. People allergic to any ingredient in this medication or to sulfonamide drugs should not take it. It is also not safe to use this medication in patients with severely impaired liver or kidney function, certain liver diseases, and certain electrolyte imbalances. Patients with a history of angioedema or allergic reactions should also avoid this medication. This medication can affect electrolyte balance, especially potassium and sodium levels, so regular blood tests are necessary. Symptoms like dizziness or drowsiness may appear, so caution should be taken when driving or operating machinery. Potassium supplements should not be taken without consulting a doctor, and special care is needed if there is dehydration due to excessive sweating, diarrhea, or vomiting. This medication may interact with other drugs, so inform your doctor or pharmacist if you are taking any other medications. The hydrochlorothiazide component can cause sensitivity to sunlight, so one should take precautions to protect the skin and use sunscreen while on this medication. Particular caution is needed for children and the elderly, and safety in pediatric patients has not been established. In case of overdose, symptoms such as hypotension, electrolyte abnormalities, and dizziness may occur, requiring immediate medical attention. This medication should be stored in a tightly closed container to protect it from moisture and direct sunlight, out of the reach of children.

Side effects

headache, dizziness, nasopharyngitis, fatigue, low back pain, cough, upper respiratory infection, diarrhea, joint pain, abdominal pain, upper abdominal pain, blurred vision, visual disturbances, anxiety, arthritis, bronchitis, acute bronchitis, chest pain, orthostatic dizziness, dry mouth, dyspepsia, dyspnea, erectile dysfunction, enteritis, hyperhidrosis, sensory loss, insomnia, hypokalemia, hypotension, influenza, muscle cramps, myalgia, nausea, nasal congestion, epistaxis, throat pain, otitis media, limb pain, paresthesia, pharyngodynia, fever, sinus congestion, sinusitis, drowsiness, leg cramps, frequent urination, palpitations, rash, ligament sprain, syncope, tachycardia, tinnitus, urinary tract infection, viral infection, edema, peripheral edema, asthenia, angioedema, pruritus, serum sickness, vasculitis, alopecia, renal impairment, myalgia, anaphylactoid symptoms, hepatitis, renal failure, hyperkalemia, hyponatremia, shock, loss of consciousness, agranulocytosis, leukopenia, thrombocytopenia, aplastic anemia, hemolytic anemia, necrotizing vasculitis, toxic epidermal necrolysis, interstitial pneumonia, pulmonary edema, systemic lupus erythematosus exacerbation, hypoglycemia, rhabdomyolysis, AST elevation, palpitations, edema, weakness, hypertriglyceridemia, creatine kinase elevation, hemoglobin reduction, thrombocytopenia, serum potassium increase, dizziness, vasculitis, elevated liver function tests, angioedema, rash, vesicular dermatitis, renal failure, joint pain, weakness, low back pain, insomnia, decreased libido, nausea, pharyngitis, rhinitis, sinusitis, upper respiratory infection, acute respiratory distress syndrome, pneumonia, pulmonary edema, acute renal failure, renal impairment, erythema multiforme, fever, muscle cramps, acute angle-closure glaucoma, choroidal effusion, hypokalemia, elevated serum lipids, hyponatremia, hypomagnesemia, hyperuricemia, hypercalcemia, hypochloremic metabolic alkalosis, hyperglycemia, diabetes, urticaria, skin rash, photosensitivity reactions, necrotizing vasculitis, cutaneous lupus erythematosus, decreased appetite, vomiting, abdominal discomfort, constipation, gastrointestinal discomfort, pancreatitis, intrahepatic cholestasis, jaundice, orthostatic hypotension, cardiac arrhythmia, sensory loss, sedation, headache, sleep disorders, depression, paresthesia, visual impairment, thrombocytopenia, leukopenia, agranulocytosis, bone marrow failure, hemolytic anemia, erectile dysfunction, hypersensitivity reactions, dyspnea, angioedema, vomiting, hypovolemia, arrhythmia, muscle rigidity

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture. It is advisable to keep the storage temperature below 30 degrees Celsius. This will help maintain the efficacy of the medication for a longer period and prevent deterioration.

Appearance and packaging

Appearance

Dark red oval film-coated tablets

Package unit

98 tablets (14 tablets/PTP x 7)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.